SCHEMBL6270232

SCHEMBL6270232

Cn1cnc2c(N)nc(C3CCCCC3)nc21

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.53
▸ PDE8B O95263 6/20 0.46
▸ ADORA2A P29274 5/20 0.45
▸ ADORA1 P30542 5/20 0.45
▸ PI4KA P42356 3/20 0.41
▸ PI4K2B Q8TCG2 3/20 0.41
▸ PI4K2A Q9BTU6 3/20 0.41
▸ PI4KB Q9UBF8 3/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ ADORA3 P0DMS8 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089517 0.98 CDK1 (0.54) CDK1PDE8BADORA2AADORA1PI4KA
SCHEMBL7738505 0.80 CDK1 (0.60) CDK1PDE8BADORA2AADORA1PI4KA
SCHEMBL28126184 0.77 PDE8B (0.35) PDE8B
SCHEMBL7438827 0.75 PI4KA (0.52) PDE8BADORA2API4KAPI4K2BPI4K2A
SCHEMBL232039 0.74 ADORA2A (0.55) CDK1PDE8BADORA2AADORA1PI4KA
SCHEMBL9233825 0.74 CDK1 (0.47) CDK1ADORA2AADORA1
SCHEMBL6270235 0.74 CDK1 (0.47) CDK1ADORA2AADORA1
SCHEMBL15354448 0.73 CDK2 (0.63) CDK1PDE8BADORA2AADORA1PI4KA
SCHEMBL15354446 0.73 CDK1 (0.63) CDK1PDE8BADORA2AADORA1PI4KA
SCHEMBL9482601 0.73 PDE8B (0.45) PDE8B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106456580-A Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof 科罗拉多州立大学董事会法人团体 2017-02-22 — — CN disclosed
EP-0778836-B1 SUBSTITUTED 9-ALKYLADENINES ADERIS PHARMACEUTICALS INC (US) 2005-12-28 — — EP disclosed
EP-1602657-A2 Substituted 9-alkyladenines Discovery Therapeutics, Inc. (US) 2005-12-07 — — EP disclosed
EP-0778836-A4 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS INC (US) 1998-02-04 — — EP disclosed
EP-0778836-A1 SUBSTITUTED 9-ALKYLADENINES Discovery Therapeutics, Inc. (US) 1997-06-18 — — EP disclosed
WO-1996006845-A1 SUBSTITUTED 9-ALKYLADENINES DISCOVERY THERAPEUTICS, INC. (US) 1996-03-07 — — WO disclosed
Send feedback